AFLD 2010 FFJBT vs Respondent M11

4 Feb 2010

Facts
The French Federation of Tamborello (Fédération Française de Jeu de Balle au Tambourin, FFJBT) charges respondent M11 for a violation of the Anti-Doping rules. During a match on August 16, 2009, a sample was taken for doping test purposes. Analysis of the sample showed the presence of norfenfluramine. Norfenfluramine is a prohibited substance according the World Anti-Doping Agency (WADA) prohibited list.

History
Respondent has no idea how the prohibited substance had entered her body. She had received treatment for a knee injury, there is a possibility that medication she took caused the positive test.

Decision

1. The sanction is a period of ineligibility of two years in which respondent can't take part in competition or manifestation organized or authorized by the FFJBT.
2. The decision (5 months period of ineligibility), dated December 1, 2009, of the disciplinary committee of the FFJBT should be modified.
3. The sanction starts on the date of the notification.
4. The decision will be published and sent to the parties involved.

AFLD 2010 FSGT vs Respondent M10

4 Feb 2010

Facts
The French Federation of Workers and Amateurs in sports (Fédération Sportive et Gymnique du Travail (FSGT) charges Respondent M10 for a violation of the Anti-Doping Rules. During a cycling contest on June 1, 2009, a sample was taken for doping test purposes. The analysis showed a high TE ratio and a spectrometric analysis shows the origin of exogenous testosterone. Exogenous testosterone is a prohibited substance according the World Anti-Doping Agency (WADA) prohibited list and is regarded as a specified substance.

History
The respondent didn't provide any information about how the prohibited substance had entered his body.

Decision
1. The sanction is a period of ineligibility of two years in which respondent can't take part in competition or manifestations organized or authorized by French sport federations.
2. The present decision will start on the date of notification.
3. The decision will be published and sent to the parties involved.

AFLD 2010 FFTri vs Respondent M09

4 Feb 2010

Facts
The French Triathlon Federation (Fédération Française de Triathlon, FFTri) charges respondent M09 for a violation of the Anti-Doping Rules. During a triathlon on August 15, 2009, a sample was collected for doping control purposes. The analysis of the sample showed the presence of betamethasone. Betamethasone is a prohibited substance according the World Anti-Doping Agency (WADA) prohibited list and is regarded as a specified substance.

History
The respondent didn't provide any information about how the prohibited substance had entered his body.

Decision
1. The decision is a period of ineligibility of one year in which respondent can't take part in competition and manifestation organized or authorized by the FFTri as pronounced in the decision, dated November 17, 2009, by the disciplinary committee of the FFTri and extended to all relevant French sport federations.
2. The present decision will start on the date of notification.
5. The decision will be published and sent to the parties involved.

AFLD 2010 FFBT vs Respondent M08

21 Jan 2010

Facts
The French Federation of Ball-Trap and Ball Shooting (Fédération Française de Ball-Trap et de Tir a Balle, FFBT) charges respondent M08 for a violation of the Anti-Doping Rules. During a contest on July 19, 2009, a sample was taken for doping test purposes. The sample showed the presence of metabolites of cannabis. Cannabis is a prohibited substance according the World Anti-Doping Agency (WADA) prohibited list and is regarded as a specified substance.

History
The respondent admits in writing the use of the prohibited substance, but denies that there was intention to enhance athletic performance.

Decision
1. The sanction is a four monhts period of ineligibility in which respondent can't take part in competition or sport manifestations organized or authorized by the FFBT.
2. The decision will start on the date of notification.
3. The decision will be published and sent to the parties involved.

AFLD 2010 FFR vs Respondent M07

21 Jan 2010

Facts
The French Rugby Federation (Fédération Française de Rugby, FFR) charges respondent M07 for a violation of the Anti-Doping Rules. During a math on May 29, 2009, a sample was taken for doping test purposes. The analysis of the sample showed the presence of salbutomol. Salbutomol is a prohibited substance according the World Anti-Doping Agency (WADA) prohibited list and is regarded as a specified substance.

History
The respondent uses a inhalator to treat asthma. The medication for this inhaler contains the prohibited substance. There was an application for a therapeutic use exemption (TUE) but the physician failed to enclose enough details. There was no intention to enhance sport performance.

Decision
1. The respondent is acquitted
2. The decision will start on the date of notification.
3. The decision will be published and sent to the parties involved.

Affidavit Piero Boccarossa [USADA vs Lance Armstrong October 10, 2012]

24 Sep 2012

Affidavit Piero Boccarossa [USADA vs Lance Armstrong October 10, 2012] September 24, 2012

Mr. Piero Boccarossa testified to USADA about the conversations he had with his close friend Betsy Andreu who also testified to USADA.
Mr. Boccarossa stated that Betsy was upset after her visit with Mr. Andreu to Lance Armstrong in the Indiana University Hospital on 27 October 1996 where Armstrong was for a cancer treatment.
In a full room she heard Lance Armstrong confessing to his doctors that he had used performance enhancing drugs. Also Betsy Andreu shared her concern with Mr. Boccarossa about the use of doping by Mr. Armstrong as professional cyclist.

Affidavit Betsy Andreu [USADA vs Lance Armstrong October 10, 2012]

21 Sep 2012

Affidavit Betsy Andreu [USADA vs Lance Armstrong October 10, 2012]
September 21, 2012

Ms. Betsy Andreu is the wife of professional cyclist and later assistant cycling director Frankie Andreu.
Mr. and Ms. Andreu testified that they visited Lance Armstrong in the Indiana University Hospital on 27 October 1996 where Armstrong was for a cancer treatment. In a full room Lance Armstrong confessed to his doctors he had used performance enhancing drugs: EPO, testosterone, growth hormone, cortisone and steroids.

On several occasions she was with Mr. Frankie Andreu in Europe where he rode races as member of the professional cycling teams. As a result Ms. Andreu testified to USADA about the widespread trafficking, possession and distribution of prohibited substances and discussions about doping in these professional cycling teams. She stated about the involvement in doping of Mr. Andreu, Lance Armstrong, other accompliced riders, medical doctors and officials.
Also she testified about the altercations between Mr. Andreu and Lance Armstrong.

Affidavit Volodymyr Bileka [USADA vs Lance Armstrong October 10, 2012]

10 Nov 2010

Affidavit Volodymyr Bileka [USADA vs Lance Armstrong October 10, 2012] November 10, 2010

Mr. Volodymyr Bileka is an Ukrainian professional cyclist since 2002 and rode in the professional teams of Landbouwkrediet-Colnago, Discovery Channel, Silence-Lotto, Amore & Vita-Conad and Konya Torku Şeker Spor. In 2008 a 2 year period of ineligibility was imposed on Mr. Bileka after he tested positive erythropoietin (EPO).
Hereafter Mr. Bileka admitted to the Italian judicial branch the use of erythropoietin (EPO). He testified about the involvement of Dr. Michele Ferrari in doping, including through advice regarding the use of EPO and blood doping, in 2007, 2008, 2009 and 2010.

AFLD 2010 FFC vs Respondent M06

21 Jan 2010

Facts
The French Cycling Federation (Fédération Française de Cyclisme, FFC) charges respondent M06 for a violation of the Anti-Doping Rules. During a cycling event on May 17, 2009, a sample was taken for doping test purposes. The analysis of the sample showed the presence of prednisolone and prednisone which are regarded as prohibited substances according the World Anti-Doping Agency (WADA) prohibited list. These substances are regarded as a specified substances.

History
The cause of the positive test is medication the respondent uses to treat allergy. He has reports which show the results of allergy tests.

Decision
1. The decision, dated October 16, 2009, of the disciplinary committee of the FFC should be modified (a warning was given).
2. The sanction will be a period of ineligibility of one month.
3. The decision starts on the date of notification.
4. The decision will be published and sent to the parties involved.

Affidavit Filippo Simeoni [USADA vs Lance Armstrong October 10, 2012]

5 Oct 2012

Affidavit Filippo Simeoni [USADA vs Lance Armstrong October 10, 2012] October 5, 2012

Mr. Filippo Simeoni is an Italian professional cyclist between 1995 and 2009 and rode in the professional teams of Carrera Jeans-Tassoni, Asics-CGA, Riso Scotti, Amica Chips, Cantina Tollo-Acqua e Sapone, Domina Vacanze, Naturino, Aurum Hotels and Ceramica Flaminia-Bossini Docce.
Mr. Simeoni admitted to the Italian judicial branch, and hereafter to USADA, the use of erythropoietin (EPO) and testosterone.

Simeoni was treated by doctor Michele Ferrari, who was also Armstrong's doctor. Simeoni testified in court that he began with doping in 1993, that Dr. Ferrari had prescribed him doping products such as EPO and Human Growth Hormone in 1996 and 1997, and that Ferrari also gave him instructions on how to use these products. Other involved cyclists in the same investigation denied their involvement in doping in front of the law enforcement agency.
After Simeoni’s testimony against Dr. Ferrari became known, Lance Armstrong used his position as a globally recognized sports icon to verbally attack Simeoni, calling him a liar in media interviews.
Simeoni testified about his altercations with Armstrong at the 2004 Tour de France.

Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin